{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:14:35Z","timestamp":1778181275388,"version":"3.51.4"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T00:00:00Z","timestamp":1359936000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0055299","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T16:57:47Z","timestamp":1359997067000},"page":"e55299","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Incidence and Risk Factors for Extensively Drug-Resistant Tuberculosis in Delhi Region"],"prefix":"10.1371","volume":"8","author":[{"given":"Chhavi","family":"Porwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayani","family":"Makkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayant N.","family":"Banavaliker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmud","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupak","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuj K.","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Digambar","family":"Behera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitendra Nath","family":"Pande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urvashi B.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,2,4]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2012) Global tuberculosis report; WHO\/HTM\/TB\/2012.6, ISBN 978 92 4 156450 2. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/publications\/global_report\/en\/index.html\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/publications\/global_report\/en\/index.html<\/ext-link>. Accessed 2013 Jan 5."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1183\/09031936.00001307","article-title":"125 years after Robert Koch\u2019s discovery of the tubercle bacillus: the new XDR-TB threat. Is \u201cscience\u201d enough to tackle the epidemic?","volume":"29","author":"GB Migliori","year":"2007","journal-title":"EurRespir J"},{"key":"ref3","first-page":"2792","article-title":"\u201cNotice to Readers: Revised Definition of Extensively Drug-R Tuberculosis\u201d","volume":"(23)","year":"2006","journal-title":"JAMA: the Journal of the American Medical Association (American Medical Association) 296"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1128\/JCM.00803-09","article-title":"Multicenter Evaluation of Bactec MGIT 960 System for Second-Line Drug Susceptibility Testing of Mycobacterium tuberculosis Complex","volume":"47","author":"SY Grace Lin","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1128\/JCM.01171-08","article-title":"Rapid Detection of Mycobacterium tuberculosis Resistance to Second-Line Drugs by Use of the Manual Mycobacterium Growth Indicator Tube System","volume":"46","author":"A Martin","year":"2008","journal-title":"J Clin Microbiol"},{"key":"ref6","unstructured":"World Health Organization (2010) Multidrug and Extensively Drug-resistant Tb (M\/XDR-TB): 2010 Global report on surveillance and response (WHO\/HTM\/TB\/2010.3)."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3201\/eid1309.070443","article-title":"Extensively Drug-Resistant <italic>Mycobacterium tuberculosis<\/italic>, India","volume":"13","author":"R Mondal","year":"2007","journal-title":"Emer Infectious Dis"},{"key":"ref8","first-page":"243","article-title":"First- and second-line drug resistance patterns among previously treated tuberculosis patients in India","volume":"14","author":"CN Paramasivan","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref9","unstructured":"Sharma SK, George N, Kadhiravan T, Saha PK, Mishra HK, <etal>et al<\/etal>.. (2009) Prevalence of extensively drug- resistant tuberculosis among patients with multidrug- resistant tuberculosis: a retrospective hospital-based study. Indian J Med Res 392\u2013395."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1128\/AAC.00661-10","article-title":"Emergence and Molecular Characterization of Extensively Drug-R Mycobacterium tuberculosis Clinical Isolates from the Delhi Region in India","volume":"54","author":"A Khanna","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/JCM.00113-11","article-title":"Can mutation detection accurately predict XDR- TB: study from a tertiary care centre India","volume":"49(4)","author":"K Ajbani","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e9527","DOI":"10.1371\/journal.pone.0009527","article-title":"Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in India","volume":"5(3)","author":"V Balaji","year":"2010","journal-title":"Plos One"},{"key":"ref13","unstructured":"Kent PT, Kubica GP (1985) Public health mycobacteriology: a guide for the level III laboratory. Atlanta, Ga.: U.S. Department of Health and Human Services\/Public Health Service\/Centers for Disease Control."},{"key":"ref14","unstructured":"Siddiqi SH, RuschGerdes S (2006) MGIT procedure manual. Geneva, Switzerland: Foundation for Innovative New Diagnostics, 2006."},{"key":"ref15","first-page":"1449","article-title":"Drug susceptibility testing of <italic>Mycobacterium tuberculosis<\/italic> against second-line drugs using the Bactec MGIT 960 System","volume":"12","author":"C Rodrigues","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"R\u00fcsch-Gerdes S, Pfyffer GE, Casal M, Chadwick M, Siddiqi S (2006) Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of <italic>M. tuberculosis<\/italic> to classical second line drugs and newer antimicrobials. J ClinMicrobiol 688\u201392.","DOI":"10.1128\/JCM.44.3.688-692.2006"},{"key":"ref17","unstructured":"World Health Organization (2008) Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs (WHO\/HTM\/TB\/2008.392)."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/590009","article-title":"Extensively drug-R tuberculosis in california, 1993\u20132006","volume":"47","author":"R Banerjee","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref19","first-page":"430","article-title":"Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMp068273","article-title":"XDR tuberculosis-implications for global public health","volume":"356","author":"M Raviglione","year":"2007","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12038-008-0078-8","article-title":"Multidrug resistant to extensively drug resistant tuberculosis: What is next?","volume":"33","author":"A Jain","year":"2008","journal-title":"J Biosci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/QAD.0b013e3282f125c9","article-title":"High rate of extensively drug- resistant tuberculosis in Indian AIDS patients","volume":"21","author":"S Singh","year":"2007","journal-title":"AIDS"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pmed.0040050","article-title":"XDR-TB in South Africa: no time for denial or complacency","volume":"4","author":"JA Singh","year":"2007","journal-title":"PLoS medicine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/524017","article-title":"Extensively Drug- resistant Tuberculosis in South Korea: Risk Factors and Treatment Outcomes among Patients at a Tertiary Referral Hospital","volume":"46","author":"CY Jeon","year":"2008","journal-title":"Clinical Infectious Diseases"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(12)60734-X","article-title":"Prevalence of and risk factors for resistance to second-line drugs in people with multidrug- resistant tuberculosis in eight countries: a prospective cohort study","volume":"380","author":"T Dalton","year":"2012","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1086\/597010","article-title":"Multidrug- resistant Tuberculosis (TB) resistant to Fluoroquinolones and Streptomycin but Susceptible to Second-Line Injection Therapy Has a Better Prognosis than Extensively Drug- resistant TB","volume":"48","author":"ED Chan","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"ref27","first-page":"99","article-title":"Genotypic diversity of extensively drug- resistant tuberculosis (XDR-TB) in South Africa","volume":"12","author":"CK Mlambo","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1128\/AAC.49.8.3192-3197.2005","article-title":"Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium tuberculosis","volume":"49","author":"CE Maus","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(08)70260-3","article-title":"Extensively drug-R tuberculosis","volume":"9","author":"M Jassal","year":"2009","journal-title":"Lancet Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0055299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T23:29:26Z","timestamp":1539991766000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0055299"}},"subtitle":[],"editor":[{"given":"Igor","family":"Mokrousov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,4]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0055299","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,4]]}}}